BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/30/2024 9:47:16 AM | Browse: 307 | Download: 852
Publication Name World Journal of Diabetes
Manuscript ID 99928
Country Brazil
Received
2024-08-04 19:34
Peer-Review Started
2024-08-05 01:14
First Decision by Editorial Office Director
2024-10-12 04:05
Return for Revision
2024-10-12 04:05
Revised
2024-10-25 03:54
Publication Fee Transferred
Second Decision by Editor
2024-11-04 02:40
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2024-11-04 08:07
Articles in Press
2024-11-04 08:07
Edit the Manuscript by Language Editor
2024-11-21 08:23
Typeset the Manuscript
2024-11-27 09:05
Publish the Manuscript Online
2024-12-30 09:47
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Letter to the Editor
Article Title Glucagon-like peptide-1 and impaired counterregulatory responses to hypoglycemia in type 1 diabetes
Manuscript Source Invited Manuscript
All Author List Gabriel Reis Rocha and Fabrício Freire de Melo
ORCID
Author(s) ORCID Number
Gabriel Reis Rocha http://orcid.org/0000-0002-3090-0726
Fabrício Freire de Melo http://orcid.org/0000-0002-5680-2753
Funding Agency and Grant Number
Funding Agency Grant Number
Industrial Technological Initiation Scholarship of National Council for Scientific and Technological Development, CNPq No. 0932204294929829
CNPq Research Productivity Fellow No. 4357511882624145
Corresponding Author Fabrício Freire de Melo, PhD, Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Rua Hormindo Barros, 58, Quadra 17, Lote 58, Vitória da Conquista 45065-430, Bahia, Brazil. freiremeloufba@gmail.com
Key Words Glucagon-like peptide 1; Type 1 diabetes mellitus; Counterregulatory hypoglycemic dysfunction; Hypoglycemia unawareness; Glucagon; Sympathoadrenal system
Core Tip Hypoglycemia is a common and significant phenomenon in diabetes type 1, with recurrent episodes causing progressive dysfunction in glycemic counterregulation and reduced hypoglycemia awareness. The involvement of glucagon-like peptide 1 in this impairment is under investigation, but the pathophysiology is complex and multifactorial, involving various hormones and central receptors. Notwithstanding, studies on glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus have shown promising benefits and a favorable safety profile.
Publish Date 2024-12-30 09:47
Citation

Rocha GR, de Melo FF. Glucagon-like peptide-1 and impaired counterregulatory responses to hypoglycemia in type 1 diabetes. World J Diabetes 2025; 16(2): 99928

URL https://www.wjgnet.com/1948-9358/full/v16/i2/99928.htm
DOI https://dx.doi.org/10.4239/wjd.v16.i2.99928
Full Article (PDF) WJD-16-99928-with-cover.pdf